Ikarian Capital’s Wave Life Sciences WVE Stock Holding History

Ikarian Capital’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$496K	Hold	85,285	–	–	0.05%	119
2026 Q1	$618K	Hold	85,285	–	–	0.05%	123
2025 Q4	$1.45M	Sell	85,285 -10,670	-11%	-$108K	0.11%	120
2025 Q3	$702K	Sell	95,955 -65,182	-40%	-$527K	0.07%	132
2025 Q2	$1.05M	Buy	+161,137	New	+$1.06M	0.2%	82
2024 Q4	–	Sell	-544,265	Closed	-$4.46M	–	208
2024 Q3	$4.46M	Sell	544,265 -30,823	-5%	-$184K	0.62%	49
2024 Q2	$2.87M	Sell	575,088 -15,000	-3%	-$85.6K	0.5%	48
2024 Q1	$3.64M	Buy	+590,088	New	+$2.95M	0.4%	63
2022 Q3	–	Sell	-98,039	Closed	-$318K	–	162
2022 Q2	$318K	Sell	98,039 -950,000	-91%	-$1.83M	0.06%	109
2022 Q1	$2.1M	Buy	1,048,039 +54,558	+5%	+$134K	0.28%	65
2021 Q4	$3.12M	Hold	993,481	–	–	0.46%	49
2021 Q3	$4.87M	Buy	+993,481	New	+$6.02M	0.34%	68

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Ikarian Capital's WVE Position: Q2 2026 in Review

Ikarian Capital held its Wave Life Sciences (WVE) position steady in Q2 2026 at 85,285 shares worth $496K. The position accounts for 0.05% of the portfolio, ranked #119.

Ikarian Capital first reported a position in WVE in Q3 2021 and has held it in 12 quarters since. The position peaked at $4.87M in Q3 2021. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Ikarian Capital held 85,285 shares of Wave Life Sciences worth $496K as of Q2 2026.
Ikarian Capital left its Wave Life Sciences share count unchanged in Q2 2026.
Wave Life Sciences made up 0.05% of Ikarian Capital's portfolio in Q2 2026, its #119 holding.
Ikarian Capital first reported a position in Wave Life Sciences in Q3 2021 and has held it in 12 quarters since.
Ikarian Capital's Wave Life Sciences position peaked at $4.87M in Q3 2021.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.